Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. ETF
  3. BIAF
BIAF logo

BIAF

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

BIAF News

bioAffinity Technologies Unveils New Diagnostic Advances for Asthma Treatment

Mar 03 2026Newsfilter

CyPath® Lung Test Supports Noninvasive Surveillance Strategy

Feb 19 2026Newsfilter

bioAffinity Showcases CyPath® Lung Cancer Detection Technology with 92% Sensitivity

Dec 03 2025Newsfilter

bioAffinity Technologies Sees Rapid Month-Over-Month Increase in CyPath® Lung Test Volume

Nov 05 2025Newsfilter

bioAffinity Technologies, Inc. Completes $1.8 Million Registered Direct Offering of Common Stock at Market Price in Accordance with Nasdaq Regulations

Oct 09 2025Newsfilter

WallachBeth Capital Announces The Closing of bioAffinity Technologies $1.8M Registered Direct Financing of Common Stock Priced At-The-Market Under Nasdaq Rules

Oct 09 2025PRnewswire

bioAffinity Technologies, Inc. Reveals About $1.8 Million Registered Direct Offering of Common Stock Priced According to Nasdaq Regulations

Oct 08 2025Newsfilter

bioAffinity Technologies initiates $1.8M direct funding round

Oct 08 2025SeekingAlpha

bioAffinity Technologies Completes $4.8 Million Public Offering

Sep 30 2025Newsfilter

WallachBeth Capital Announces Closing of bioAffinity Technologies Public Offering for $4.8m

Sep 30 2025PRnewswire

Energy Fuels, Firefly Aerospace, and Other Major Stocks Decline in Tuesday's Pre-Market Trading

Sep 30 2025Benzinga

Wolfspeed Shares Surge Over 50%; Check Out 20 Stocks Making Moves in Premarket Trading

Sep 30 2025Benzinga

WallachBeth Capital Announces Pricing of bioAffinity Technologies Public Offering for $4.8m

Sep 29 2025PRnewswire

bioAffinity Technologies launches $4.8 million public offering as shares drop more than 30%

Sep 29 2025SeekingAlpha

Merus Shares Surge 38%; Check Out 20 Stocks Making Moves in Premarket Trading

Sep 29 2025Benzinga

Nasdaq Rises by 100 Points as US Consumer Sentiment Declines

Sep 26 2025Benzinga